Biomarkers of lesion severity in a rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION)
Yan GuoiD, Zara MehrabianiD, Mary A. JohnsoniD, Neil R. MilleriD, Amanda D. HendersoniD, John M. HamlyniD, Steven L. BernsteiniD
Abstract
The rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION) is similar in many of its pathophysiological responses to clinical NAION. However, little is known of the parameters associated with rNAION induction severity and if pre- or early post-induction biomarkers can be identified that enable prediction of lesion severity and ultimate loss of retinal ganglion cells (RGCs). Adult male Sprague-Dawley outbred rats were evaluated for various parameters including physiological characteristics (heart rate, respiratory rate, temperature, hematocrit), optic nerve head (ONH) appearance, pre- and post-induction mean diameter, and intravenous fluorescein and indocyanine green angiographic patterns of vascular leakage at 5 hours post-induction, performed using a spectral domain-optical coherence tomography (SD-OCT) instrument. These parameters were correlated with ultimate RGC loss by Brn3a (+) immunohistology. RGC loss also was correlated with the relative level of laser exposure. The severity of ONH edema 2d, but not 5hr, post induction was most closely associated with the degree of RGC loss, revealing a threshold effect, and consistent with a compartment syndrome where a minimum level of capillary compression within a tight space is responsible for damage. RGC loss increased dramatically as the degree of laser exposure increased. Neither physiological parameters nor the degree of capillary leakage 5hr post induction were informative as to the ultimate degree of RGC loss. Similar to human NAION, the rNAION model exhibits marked variability in lesion severity. Unlike clinical NAION, pre-induction ONH diameter likely does not contribute to ultimate lesion severity; however, cross-sectional ONH edema can be used as a biomarker 1-2d post-induction to determine randomization of subjects prior to inclusion in specific neuroprotection or neuroregeneration studies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 11
- FWCI
- 1.57
- Field percentile
- top 21%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Torsion-Induced Traumatic Optic Neuropathy (TITON): A Physiologically Relevant Animal Model of Traumatic Optic Neuropathy
Annie K. Ryan, Brooke Ivie Asemota, … Matthew A. Reilly·PLoS ONEPeer-reviewed·Jan 16, 2025
- Optic nerve crush does not induce retinal ganglion cell loss in the contralateral eye.
Florianne E. Schoot Uiterkamp, Margaret E. Maes, … Sandra Siegert·Investigative Ophthalmology & Visual SciencePeer-reviewed·Mar 24, 2025
- Oral supplementation with Nicotinamide Riboside treatment protects RGCs in DBA/2J mouse model
Nan Zhang, Ying Li, … Jeffrey H. Boatright·bioRxiv·Dec 3, 2024
- Early detection of retinal alteration by visible and near-infrared optical coherence tomography (vnOCT) in a dexamethasone-induced ocular hypertension mouse model
- Vitreous Inflammation as an Early Indicator of Retinal Ganglion Cell Loss Following Acute Optic Nerve Injury in Mice
Shichu Chang, Weijia Fan, … Xiaorong Liu·bioRxiv·Dec 23, 2025
- RGC-specific reversal of lipid peroxidation drives neuroprotection and vision restoration in optic nerve ischemia by targeting GPX4
Ming Yang, Jie Pan, … Yaping Joyce Liao·bioRxiv·Aug 29, 2026